EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Ejaculatory and erectile function outcomes following holmium laser enucleation of the prostate

Chinade Roper iD, Austen Slade, Ronald Caras, Thomas Shelton, Marcelino Rivera

The Prostate · 2024-06 · 84 (9) · 791-796

DOI: 10.1002/pros.24697 ↗

At a glance

Journal article in The Prostate, 2024-06. Written by Chinade Roper and 4 co-authors. Institution: Indiana University School of Medicine, Indianapolis, Indiana, USA. Major MEDLINE topics: Lasers, Solid-State, Prostatic Hyperplasia, Ejaculation, Erectile Dysfunction. Cited 18 times so far (Crossref); 19 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

Holmium laser enucleation of the prostate (HoLEP) is a surgical treatment option for benign prostatic hyperplasia (BPH). Many men develop retrograde ejaculation postprocedure, but there is conflicting evidence regarding sexual function outcomes post‐HoLEP. We sought to examine significant variations in patient‐reported erectile and ejaculatory function within 12 months post‐HoLEP. Materials and Methods We conducted a retrospective study for patients who underwent HoLEP between Nov 2018 and Feb 2022. Of the reviewed patients, 277 patients met inclusion criteria and completed pre and postoperative questionnaires, which included the Male Sexual Health Questionnaire‐ Ejaculatory Dysfunction (MSHQ‐EJD) and the International Index of Erectile Function/Sexual Health Inventory for Men (IIEF‐5/SHIM). Surveys were provided to patients up to 12 months postprocedure. Demographics and comorbidities associated with sexual dysfunction were collected. Responses to each question were analyzed to detect sub‐categorical variations in sexual function as the secondary objective. Data was analyzed by using a linear mixed model.

Results

There was a significant decline in total scores for the MSHQ‐EJD (8.70 pre‐HoLEP vs. 6.58 post HoLEP, p ≤ 0.001) including a significant decline ( p < 0.005) in questions 1–3 which assess ejaculatory ability, strength, and volume. There was not a significant decline in question 4 which assesses bother (2.552 pre‐HoLEP vs. 3.119 post‐HoLEP, p = 0.526). There was not a significant decline in the IIEF‐5/SHIM postoperatively (11.51 pre‐HoLEP vs. 13.327 post‐HoLEP, p = 0.498).

Conclusions

Patients undergoing HoLEP do not experience a decline in erectile function. Patients do experience a decline in ejaculatory function but did not find this bothersome.

Subjects

MeSH terms (MEDLINE)

Lasers, Solid-StateProstatic HyperplasiaEjaculationErectile DysfunctionProstatectomyHumansMaleAgedRetrospective StudiesMiddle AgedPostoperative ComplicationsSurveys and QuestionnairesTreatment OutcomePenile ErectionLaser Therapy

Author keywords

HoLEPejaculatory functionerectile function

Authors and institutions

  • Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Urology, Indiana University Health, Indianapolis, Indiana, USA.

ORCID profiles: Chinade Roper

Cite

APA

Roper, C., Slade, A., Caras, R., Shelton, T., & Rivera, M. (2024). Ejaculatory and erectile function outcomes following holmium laser enucleation of the prostate. The Prostate. https://doi.org/10.1002/pros.24697

Vancouver

Roper C, Slade A, Caras R, Shelton T, Rivera M. Ejaculatory and erectile function outcomes following holmium laser enucleation of the prostate. The Prostate. 2024. doi:10.1002/pros.24697

BibTeX
@article{Roper2024,
  author = {Roper, Chinade and Slade, Austen and Caras, Ronald and Shelton, Thomas and Rivera, Marcelino},
  title = {Ejaculatory and erectile function outcomes following holmium laser enucleation of the prostate},
  journal = {The Prostate},
  year = {2024},
  doi = {10.1002/pros.24697}
}
Start for free →